All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

5-Amino-1MQ for fat loss: what the evidence actually shows

jddenhamfit

TikTok creator

50.2K viewsWatch on TikTok→

Quick answer

5-amino-1MQ is an experimental NNMT inhibitor with preclinical evidence for fat mass reduction in obese mice (Rhoads et al., 2021), but it has no published human clinical trials, no FDA evaluation, and no established safety profile in people. The fat-burning mechanism differs entirely from GLP-1/GIP-based compounds like retatrutide, making direct comparisons between them unsupported by any published data. Patients interested in metabolic peptide therapy should consult a licensed provider who can assess individual risk factors before considering any investigational compound.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What did @jddenhamfit actually say?

The creator calls 5-amino-1MQ "one of my personal favorites" and claims he takes it daily. He lists four main benefits: fat burning comparable to retatrutide, energy boosting, muscle preservation during a caloric deficit, and anti-aging effects on skin, hair, and nails. He also says it "brings down inflammation." To his credit, he adds "I'm not telling you you should take it" and encourages personal research before use.

The comparison to retatrutide is the most attention-grabbing claim here. He frames 5-amino-1MQ as having that same ability to "burn that much fat, that quickly" while preserving muscle, which is a bold parallel to one of the more potent investigational weight-loss compounds currently in trials.

Does the science back this up?

Partially, but with serious caveats. The human data on 5-amino-1MQ is essentially nonexistent. What we have is early-stage animal and cell research, and the gap between those findings and the confident claims in this video is significant.

5-amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in cellular metabolism and fat storage. In a 2021 study by Rhoads et al. published in Communications Biology, mice on a high-fat diet treated with 5-amino-1MQ showed reduced fat mass and improved metabolic markers without changes in food intake. That is genuinely interesting data. The same research group published supporting mechanistic work showing NNMT inhibition raises SAM (S-adenosylmethionine) levels and affects fat cell differentiation.

However, mice are not people. There are no published randomized controlled trials in humans. The energy-boosting, hair and nail, and anti-aging claims have no direct published support in any population, human or animal.

What did they get wrong (or right)?

The fat metabolism angle is the most defensible part of this video, because the NNMT inhibition mechanism has legitimate preclinical support. Rhoads et al. (2021, Communications Biology) is a real study with real findings. Crediting 5-amino-1MQ with some metabolic activity is not unreasonable as a hypothesis worth watching.

What he got wrong is the retatrutide comparison. Retatrutide is a GIP, GLP-1, and glucagon triple receptor agonist in Phase 3 trials, with documented efficacy in humans. Saying 5-amino-1MQ has the "same" fat-burning ability is not supported by any comparative data. One is a well-studied peptide hormone analog with human trial results. The other has one mouse study. Framing them as comparable misleads viewers about the evidence hierarchy.

The anti-aging claims for skin, hair, and nails appear to be entirely speculative. NNMT inhibition has been studied in the context of cellular aging in vitro, but there is no published evidence linking 5-amino-1MQ specifically to the cosmetic benefits he describes.

What should you actually know?

5-amino-1MQ is a research compound. That label matters. It means it has not been evaluated for safety, dosing, or efficacy in humans by any regulatory body. Buying it from compounding or research chemical sources means you have no verified purity data, no clinical dosing guidance, and no post-market safety surveillance watching for adverse events.

NNMT inhibition is a genuinely interesting research target. Several academic groups are studying it for obesity, metabolic syndrome, and potentially aging-related conditions. But interesting preclinical data has a long history of not translating into safe, effective human treatments.

The energy-boosting and muscle preservation claims are particularly under-supported. No published mechanism or study directly links 5-amino-1MQ to fatigue reduction or muscle protein synthesis in humans. If you are evaluating this compound for those reasons specifically, you are acting on no evidence.

Anyone considering peptide therapy should have that conversation with a licensed clinician who can review their full health history, not a TikTok video, regardless of how enthusiastic the presenter is about their personal results.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For 5-Amino-1MQ for fat loss: what the evidence actually shows, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Comparison decision path

Use this comparison to narrow the provider review question

Direct answer

5-Amino-1MQ for fat loss: what the evidence actually shows should help you decide which option deserves a clinical review, not force a one-size answer.

Evidence check

A strong comparison should connect mechanism, evidence strength, safety, access, and cost instead of only naming a winner.

Safety check

The right choice can change based on history, medication interactions, side effects, budget, and availability.

Next step

Compare available products and select the relevant treatment page for its specific next step.

Claim verdict

The useful answer behind this video

Claim being checked

5-amino-1MQ is an experimental NNMT inhibitor with preclinical evidence for fat mass reduction in obese mice (Rhoads et al.

FormBlends verdict

5-amino-1MQ is an experimental NNMT inhibitor with preclinical evidence for fat mass reduction in obese mice (Rhoads et al., 2021), but it has no published human clinical trials, no FDA evaluation, and no established safety profile in people. The fat-burning mechanism differs entirely from GLP-1/GIP-based compounds like retatrutide, making direct comparisons between them unsupported by any published data. Patients interested in metabolic peptide therapy should consult a licensed provider who can assess individual risk factors before considering any investigational compound.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • 5-amino-1MQ is an experimental NNMT inhibitor with preclinical evidence for fat mass reduction in obese mice (Rhoads et al., 2021), but it has no published human clinical trials, no FDA evaluation, and no established safety profile in people. The fat-burning mechanism differs entirely from GLP-1/GIP-based compounds like retatrutide, making direct comparisons between them unsupported by any published data. Patients interested in metabolic peptide therapy should consult a licensed provider who can assess individual risk factors before considering any investigational compound.
  • The only published fat-loss study on 5-amino-1MQ is a 2021 mouse study (Rhoads et al., Communications Biology). Zero randomized controlled trials in humans exist as of 2024.
  • 5-amino-1MQ works by inhibiting NNMT, a completely different mechanism than GLP-1/GIP receptor agonists like retatrutide. Comparing their fat-burning effects is not supported by any published data.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • The only published fat-loss study on 5-amino-1MQ is a 2021 mouse study (Rhoads et al., Communications Biology). Zero randomized controlled trials in humans exist as of 2024.
  • 5-amino-1MQ works by inhibiting NNMT, a completely different mechanism than GLP-1/GIP receptor agonists like retatrutide. Comparing their fat-burning effects is not supported by any published data.
  • Energy boosting, muscle preservation, and anti-aging effects on skin, hair, and nails are not backed by any peer-reviewed study in humans or animals specific to this compound.
  • Because 5-amino-1MQ has no human clinical trials, there is no established safe dose range, no known drug interaction profile, and no regulatory safety data for human use.
  • NNMT inhibition is a legitimate area of metabolic research being studied at academic institutions, but interesting preclinical results frequently fail to translate into effective human treatments.
  • Buying any research compound without medical supervision means accepting unknown purity, unknown dosing risk, and no clinical follow-up if adverse effects occur.
  • Anyone considering experimental peptide therapy should work with a licensed clinician who can review personal health history and monitor outcomes, not act on social media recommendations.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

jddenhamfit · TikTok creator

50.2K views on this video

THE PEPTIDE OF THE WEEK!!! 5 AMINO-1MQ - Easily one of my personal favorites, and one I take daily. I have my bride on it as well. 💥 Here are some of the benefits of this amazing peptide. . . 💊 🔥 1. Helps Burn Fat! It works on an enzyme in your body that plays a role in how fat is stored and used. ⚡ 2. Huge energy boost! Many users say they feel more energized and less sluggish during the day. 💪 3. Helps Keep Muscle It may help you hold onto lean muscle, even while losing fat (great

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by jddenhamfit, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.